Bayer $38M ADR Securities Class Action Settlement
If you purchased or otherwise acquired Bayer American Depositary Receipts (ADRs) between May 23 2016 and July 6 2020, you could receive a cash payment from a $38 million securities class action settlement. Submit your claim by October 16 2025 to be considered for compensation.
Download Claim Form (PDF)Who is eligible?
- All persons or entities that bought or otherwise acquired publicly traded Bayer ADRs from May 23 2016 – July 6 2020.
- Includes purchases through brokerage accounts, custodial accounts, or by depositing/redeeming Bayer ordinary shares via The Bank of New York Mellon.
- Anyone who previously opted out of the litigation but now wishes to participate must submit an opt-in request to the settlement administrator by October 9 2025.
Potential payout
Payments will be calculated under a court-approved Plan of Allocation that considers:
- Date(s) you bought and/or sold Bayer ADRs
- The amount of “artificial inflation” in the share price on those dates (see Table A of the long-form notice)
The average recovery is estimated at roughly $0.15 per affected share after fees and expenses, but your payment will depend on your individual transactions and the total number of valid claims.
How to file a claim
- Gather supporting documents (broker statements, trade confirmations, etc.).
- Choose one filing method:
- File a claim online, or
- Print and mail the PDF claim form postmarked no later than Oct 16 2025.
- Mail paper claims to:
Bayer ADR Securities Litigation
c/o A.B. Data, Ltd.
P.O. Box 173084
Milwaukee, WI 53217
Important dates
| Deadline | Event |
|---|---|
| Oct 9 2025 | Opt back in (if you previously excluded yourself) |
| Oct 16 2025 | Submit claim form |
| Oct 30 2025 | Final approval (fairness) hearing |
Background of the lawsuit
Investors alleged that Bayer Aktiengesellschaft and certain executives violated federal securities laws by making false and misleading statements about:
- The company’s due-diligence process for acquiring Monsanto
- The litigation risk associated with Monsanto’s Roundup herbicide
According to plaintiffs, these statements artificially inflated the price of Bayer ADRs. When the alleged truth came to light through subsequent legal and financial events, Bayer’s share price fell, causing investor losses. Bayer denies wrongdoing but agreed to a $38 million settlement to avoid continued litigation risk and expense.
Frequently asked questions about the Bayer $38M ADR Securities Class Action Settlement
Is proof of purchase required?
Yes. You must submit brokerage statements, trade confirmations, or another authorized record showing each relevant Bayer ADR transaction.
How will I receive my payment?
Approved claimants will receive a paper check mailed to the address on the claim form.
When will payments be sent?
Checks are issued after the court grants final approval, all appeals (if any) are resolved, and claims are processed. This can take several months after the Oct 30 2025 fairness hearing.
What fees will be deducted?
The court may approve attorneys’ fees of up to $10.26 million and expenses up to $3.55 million, plus notice and administration costs. These amounts come out of the $38 million fund before payments to class members.
Where can I get more information?
Visit the official settlement website or call the administrator at 800-524-0614.
Attorney Advertising. Prior results do not guarantee a similar outcome.